122 related articles for article (PubMed ID: 24901268)
1. Factors associated with human papillomavirus vaccination completion on a catch-up schedule.
Perry R; Rankin K; Yu MC; Harwood B
Obstet Gynecol; 2014 Jul; 124(1):76-81. PubMed ID: 24901268
[TBL] [Abstract][Full Text] [Related]
2. Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States.
Adjei Boakye E; Lew D; Muthukrishnan M; Tobo BB; Rohde RL; Varvares MA; Osazuwa-Peters N
Hum Vaccin Immunother; 2018; 14(8):2016-2024. PubMed ID: 29708826
[TBL] [Abstract][Full Text] [Related]
3. Contraceptive need, counseling, and provision at the time of human papillomavirus vaccination on a catch-up schedule.
Perry R; Yu MC; Harwood B
J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):183-6. PubMed ID: 24814529
[TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus Vaccination Schedule: Adherence Among Commercially Insured Adolescents and Young Adults in the United States, 2011-2017.
Hubbard D; Shrestha S; Levitan EB; Yun H
Am J Public Health; 2020 Mar; 110(3):385-390. PubMed ID: 31944848
[No Abstract] [Full Text] [Related]
5. Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data.
Pathela P; Jamison K; Papadouka V; Kabir R; Markowitz LE; Dunne EF; Schillinger JA
J Adolesc Health; 2016 Dec; 59(6):710-715. PubMed ID: 27671357
[TBL] [Abstract][Full Text] [Related]
6. Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series.
Widdice LE; Hoagland R; Callahan ST; Kahn JA; Harrison CJ; Pahud BA; Frey SE; Berry AA; Kotloff KL; Edwards KM; Mulligan MJ; Sudman J; Nakamura A; Bernstein DI
Vaccine; 2018 Mar; 36(11):1491-1499. PubMed ID: 29428177
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing Human papillomavirus (HPV) vaccination series completion in Mississippi Medicaid.
Inguva S; Barnard M; Ward LM; Yang Y; Pittman E; Banahan BF; Kirby TR; Noble SL
Vaccine; 2020 Feb; 38(8):2051-2057. PubMed ID: 31980196
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Human Papillomavirus Vaccine Completion Among Low-Income Latina/o Adolescents.
Gerend MA; Stephens YP; Kazmer MM; Slate EH; Reyes E
J Adolesc Health; 2019 Jun; 64(6):753-762. PubMed ID: 30777636
[TBL] [Abstract][Full Text] [Related]
9. HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US.
Liu G; Kong L; Du P
Papillomavirus Res; 2016 Dec; 2():1-8. PubMed ID: 26623444
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus Vaccine: Continuation, Completion, and Missed Opportunities.
Richards MJ; Peters M; Sheeder J
J Pediatr Adolesc Gynecol; 2016 Apr; 29(2):117-21. PubMed ID: 26300233
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study.
Silverberg MJ; Leyden WA; Lam JO; Gregorich SE; Huchko MJ; Kulasingam S; Kuppermann M; Smith-McCune KK; Sawaya GF
Lancet Child Adolesc Health; 2018 Oct; 2(10):707-714. PubMed ID: 30236379
[TBL] [Abstract][Full Text] [Related]
12. The influence of free quadrivalent human papillomavirus vaccine (HPV4) on the timely completion of the three dose series.
Harper DM; Verdenius I; Harris GD; Barnett AL; Rosemergey BE; Arey AM; Wall J; Malnar GJ
Prev Med; 2014 Apr; 61():20-5. PubMed ID: 24440159
[TBL] [Abstract][Full Text] [Related]
13. Patient adherence to three dose completion of the quadrivalent human papillomavirus (HPV) vaccine in a private practice.
Rubin RF; Kuttab HM; Rihani RS; Reutzel TJ
J Community Health; 2012 Dec; 37(6):1145-50. PubMed ID: 22752532
[TBL] [Abstract][Full Text] [Related]
14. A randomized intervention of reminder letter for human papillomavirus vaccine series completion.
Chao C; Preciado M; Slezak J; Xu L
J Adolesc Health; 2015 Jan; 56(1):85-90. PubMed ID: 25438965
[TBL] [Abstract][Full Text] [Related]
15. Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009.
Hirth JM; Tan A; Wilkinson GS; Berenson AB
Cancer; 2012 Nov; 118(22):5623-9. PubMed ID: 22544681
[TBL] [Abstract][Full Text] [Related]
16. Acceptance and compliance with postpartum human papillomavirus vaccination.
Wright JD; Govindappagari S; Pawar N; Cleary K; Burke WM; Devine PC; Lu YS; Tsai WY; Lewin SN; Herzog TJ
Obstet Gynecol; 2012 Oct; 120(4):771-82. PubMed ID: 22996094
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination.
Conroy K; Rosenthal SL; Zimet GD; Jin Y; Bernstein DI; Glynn S; Kahn JA
J Womens Health (Larchmt); 2009 Oct; 18(10):1679-86. PubMed ID: 19785564
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus vaccination completion rates among gynecological providers: an institutional retrospective review.
Elsamadicy EA; Schneiter MK; Hull PC; Khabele D
Hum Vaccin Immunother; 2019; 15(7-8):1851-1855. PubMed ID: 31091165
[No Abstract] [Full Text] [Related]
19. Compliance with recommended dosing intervals for HPV vaccination among females, 13-17 years, National Immunization Survey-Teen, 2008-2009.
Dorell CG; Stokley S; Yankey D; Markowitz LE
Vaccine; 2012 Jan; 30(3):503-5. PubMed ID: 22119587
[TBL] [Abstract][Full Text] [Related]
20. HPV Vaccination Completion and Compliance with Recommended Dosing Intervals Among Female and Male Adolescents in an Inner-City Community Health Center.
Wilson RM; Brown DR; Carmody DP; Fogarty S
J Community Health; 2015 Jun; 40(3):395-403. PubMed ID: 25312867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
